Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-07-17

FDA Approved: VENLAFAXINE — Supplemental Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved Alembic Pharmaceuticals' supplemental application for a generic venlafaxine product (ANDA 078932). Venlafaxine is indicated for major depressiv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Venlafaxine (Venlafaxine)

Snippet

SUPPL AP for VENLAFAXINE (VENLAFAXINE)